7Baggers
 Sangamo Therapeutics Shares Plunge to Critical Levels  AD HOC NEWS Mon, 17 Nov 2025 07:59:05 GMT
 published on: 2025-11-15 13:19:54  newser.com Sat, 15 Nov 2025 19:19:54 GMT
 published on: 2025-11-15 01:48:25  newser.com Sat, 15 Nov 2025 07:48:25 GMT
 Research Analysts Offer Predictions for SGMO FY2025 Earnings  MarketBeat Thu, 13 Nov 2025 13:07:19 GMT
 Sangamo Therapeutics: Navigating a Critical Financial Crossroads  AD HOC NEWS Thu, 13 Nov 2025 09:50:04 GMT
 Q4 Earnings Forecast for SGMO Issued By HC Wainwright  MarketBeat Wed, 12 Nov 2025 13:08:53 GMT
 sangamo therapeutics faces critical survival test as shares plunge  AD HOC NEWS Mon, 10 Nov 2025 16:08:04 GMT
 published on: 2025-11-09 08:46:49  newser.com Sun, 09 Nov 2025 14:46:49 GMT
 published on: 2025-11-09 05:32:30  newser.com Sun, 09 Nov 2025 11:32:30 GMT
 sangamo therapeutics (sgmo) faces downgrade and pt reduction by  GuruFocus Sat, 08 Nov 2025 06:26:04 GMT
 Sangamo Therapeutics (SGMO) Faces Downgrade and PT Reduction by  GuruFocus Fri, 07 Nov 2025 13:15:54 GMT
 sangamo: q3 earnings snapshot  theheraldreview.com Fri, 07 Nov 2025 08:35:42 GMT
 Sangamo Therapeutics Reports Q3 2025 Financial Results  TipRanks Fri, 07 Nov 2025 04:45:18 GMT
 sangamo therapeutics (sgmo) reports q3 loss, lags revenue estimates  sharewise.com Fri, 07 Nov 2025 04:26:46 GMT
 Sangamo Therapeutics Inc (SGMO) Q3 2025 Earnings Call Highlights  GuruFocus Thu, 06 Nov 2025 21:13:09 GMT
 Sangamo: Q3 Earnings Snapshot  New Haven Register Thu, 06 Nov 2025 15:17:00 GMT
 Sangamo Therapeutics Inc Reports Q3 EPS of -$0.11, Missing Estim  GuruFocus Thu, 06 Nov 2025 13:50:54 GMT
 Sangamo Therapeutics (SGMO) Projects Funding into 2026 Despite C  GuruFocus Thu, 06 Nov 2025 13:50:44 GMT
 sangamo (sgmo) reports significant drop in q3 revenue  GuruFocus Thu, 06 Nov 2025 13:49:04 GMT
 sgmo projects 2025 operating expenses with neurology focus  GuruFocus Thu, 06 Nov 2025 13:42:21 GMT
 Sangamo Therapeutics, Inc. (SGMO) Q3 FY2025 earnings call transcript  Yahoo Finance Thu, 06 Nov 2025 13:30:00 GMT
 Sangamo Therapeutics (SGMO) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Sangamo Therapeutics Q3 revenue falls short, net loss widens  MarketScreener Thu, 06 Nov 2025 08:00:00 GMT
 Sangamo (SGMO) Q3 2025 Earnings Call Transcript  The Motley Fool Thu, 06 Nov 2025 08:00:00 GMT
 published on: 2025-11-04 04:55:19  newser.com Tue, 04 Nov 2025 10:55:19 GMT
 published on: 2025-10-31 05:14:43  newser.com Fri, 31 Oct 2025 10:14:43 GMT

Sangamo Therapeutics, Inc
(NASDAQ:SGMO) 

SGMO stock logo

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a t...

Founded: 1995
Full Time Employees: 354
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends